Vepdegestrant: all 23 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver FunctionRecruitingNCT07231991Phase 1Report a problem
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingNCT01042379Phase 2Report a problem
- A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Active, not recruitingNCT06206837Phase 1/2Results postedReport a problem
- A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy AdultsCompletedNCT05673889Phase 1Results postedReport a problem
- A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerActive, not recruitingNCT05654623Phase 3Results postedReport a problem
- A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy AdultsCompletedNCT05652660Phase 1Results postedReport a problem
- A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryCompletedNCT05549505Phase 2Results postedReport a problem
- A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy AdultsCompletedNCT05538312Phase 1Results postedReport a problem
- A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)Active, not recruitingNCT05463952Phase 1Results postedReport a problem
- A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast CancerCompletedNCT04072952Phase 1/2Results postedReport a problem
- A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy AdultsCompletedNCT06911788Phase 1Report a problem
- A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy AdultsCompletedNCT06645938Phase 1Report a problem
- A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy AdultsCompletedNCT06347861Phase 1Report a problem
- A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine VepdegestrantCompletedNCT06275841Phase 1Report a problem
- A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called MidazolamCompletedNCT06256510Phase 1Report a problem
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)TerminatedNCT06125522Phase 1/2Report a problem
- A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy ParticipantsCompletedNCT06005688Phase 1Report a problem
- A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy AdultsCompletedNCT05930925Phase 1Report a problem
- Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast CancerActive, not recruitingNCT05909397Phase 3Report a problem
- A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in ChinaCompletedNCT05732428Phase 1Report a problem
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)TerminatedNCT05573555Phase 1/2Report a problem
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)Active, not recruitingNCT05548127Phase 1/2Report a problem
- ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast CancerCompletedNCT05501769Phase 1Report a problem